Mallinckrodt, Medtronic Announce Clinical and Commercial Collaboration

Mallinckrodt MNK announced today that it has entered into a multiyear agreement with Medtronic MDT to advance availability in the U.S. of intrathecal therapeutics for the treatment of chronic pain and severe spasticity. See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceContractsManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!